Concordance Between Self-Report and Performance-Based Measures of Everyday Functioning in HIV-Associated Neurocognitive Disorders

Overview

Journal AIDS Behav

Specialty Infectious Diseases

Date 2017 Jan 22

PMID 28108876

Citations 7

Authors

Talia N Shirazi

Angela C Summers

Bryan R Smith

Sally R Steinbach

Suad Kapetanovic

Avindra Nath

Joseph Snow

Affiliations

Soon will be listed here.

Abstract

Self-report is typically used to differentiate between asymptomatic neurocognitive impairment (ANI) and mild neurocognitive disorder (MND) in the assessment of HIV-associated neurocognitive disorders (HAND). Yet, it is unclear whether the lack of self-reported functional impairments in individuals with ANI is indicative of a genuine absence of functional impairment, or of inaccurate self-reports. In the present study, we examined the relationship between previously validated self-report (patient's assessment of own functioning inventory; instrumental activities of daily living inventory) and performance-based (the Texas Functional Living Scale) measures of functional abilities in 112 virologically-controlled HIV-infected, and 40 well-matched, HIV-uninfected participants. Participants with symptomatic cognitive impairment (CI) had significantly lower overall scores and higher rates of impairment on a performance-based measure of everyday functioning as compared to participants with either asymptomatic CI or normal cognitive performance (WNL [within normal limits]; all p < 0.05), while asymptomatic CI and WNL participants had comparable rates of impairment and performance within the average range on the performance-based measure. The concordance between self-report and performance-based measures of everyday functioning in asymptomatic and symptomatic CI provide support for ANI and MND as clinically distinct diagnostic entities, and support the use of self-reports as appropriate measures of everyday functioning in the diagnosis of HAND.

Citing Articles

Neurocognitive Dysfunction With Neuronal Injury in People With HIV on Long-Duration Antiretroviral Therapy.

McMahan C, Dietrich D, Horne E, Kelly E, Geannopoulos K, Siyahhan Julnes P Neurology. 2023; 100(24):e2466-e2476.

PMID: 37105760 PMC: 10264056. DOI: 10.1212/WNL.0000000000207339.

Age, cognitive status, and accuracy of ADL self-reports in adults living with HIV.

Clarke Y, Morgello S, Byrd D AIDS Care. 2022; 35(2):289-295.

PMID: 36007132 PMC: 11246603. DOI: 10.1080/09540121.2022.2113759.

Functional Impairment and Cognitive Symptoms Among People with HIV Infection on Chronic Opioid Therapy for Pain: The Impact of Gabapentin and Other Sedating Medications.

Kim T, Samet J, Lodi S, Kimmel S, Forman L, Lira M AIDS Behav. 2022; 26(12):3889-3896.

PMID: 35737281 PMC: 11055610. DOI: 10.1007/s10461-022-03716-3.

Association of White Matter Hyperintensities With HIV Status and Vascular Risk Factors.

Mina Y, Wu T, Hsieh H, Hammoud D, Shah S, Lau C Neurology. 2021; 96(14):e1823-e1834.

PMID: 33637630 PMC: 8105972. DOI: 10.1212/WNL.0000000000011702.

Deep Phenotyping of HIV Neurocognitive Complications Among Individuals Residing in High-Income Countries.

Paul R, Garcia-Egan P, Bolzenius J, Mannarino J Curr Top Behav Neurosci. 2021; 50:245-269.

PMID: 33442841 DOI: 10.1007/7854_2020_185.

References

Carey C, Woods S, Gonzalez R, Conover E, Marcotte T, Grant I . Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004; 26(3):307-19. DOI: 10.1080/13803390490510031. View

Perry W, Hilsabeck R, Hassanein T . Cognitive dysfunction in chronic hepatitis C: a review. Dig Dis Sci. 2007; 53(2):307-21. DOI: 10.1007/s10620-007-9896-z. View

Richardson-Vejlgaard R, Dawes S, Heaton R, Bell M . Validity of cognitive complaints in substance-abusing patients and non-clinical controls: the Patient's Assessment of Own Functioning Inventory (PAOFI). Psychiatry Res. 2009; 169(1):70-4. PMC: 2741396. DOI: 10.1016/j.psychres.2008.06.018. View

Nurmi M, Jehkonen M . [Recognition and rehabilitation of impaired awareness of illness, i.e. anosognosia in a patient with cerebrovascular disease]. Duodecim. 2015; 131(3):228-34. View

Thames A, Kim M, Becker B, Foley J, Hines L, Singer E . Medication and finance management among HIV-infected adults: the impact of age and cognition. J Clin Exp Neuropsychol. 2010; 33(2):200-9. PMC: 3616485. DOI: 10.1080/13803395.2010.499357. View

Emlet C . An examination of the social networks and social isolation in older and younger adults living with HIV/AIDS. Health Soc Work. 2006; 31(4):299-308. DOI: 10.1093/hsw/31.4.299. View

Raison C, Capuron L, Miller A . Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2005; 27(1):24-31. PMC: 3392963. DOI: 10.1016/j.it.2005.11.006. View

Blackstone K, Moore D, Heaton R, Franklin Jr D, Woods S, Clifford D . Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc. 2011; 18(1):79-88. PMC: 3882265. DOI: 10.1017/S135561771100141X. View

. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology. 1991; 41(6):778-85. DOI: 10.1212/wnl.41.6.778. View

10.

Cysique L, Brew B . Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. J Neurovirol. 2011; 17(2):176-83. DOI: 10.1007/s13365-011-0021-x. View

11.

Juengst S, Skidmore E, Pramuka M, McCue M, Becker J . Factors contributing to impaired self-awareness of cognitive functioning in an HIV positive and at-risk population. Disabil Rehabil. 2011; 34(1):19-25. PMC: 3339490. DOI: 10.3109/09638288.2011.587088. View

12.

Rao D, Pryor J, Gaddist B, Mayer R . Stigma, secrecy, and discrimination: ethnic/racial differences in the concerns of people living with HIV/AIDS. AIDS Behav. 2007; 12(2):265-71. DOI: 10.1007/s10461-007-9268-x. View

13.

Gil R, Arroyo-Anllo E, Ingrand P, Gil M, Neau J, Ornon C . Self-consciousness and Alzheimer's disease. Acta Neurol Scand. 2001; 104(5):296-300. DOI: 10.1034/j.1600-0404.2001.00280.x. View

14.

Thames A, Becker B, Marcotte T, Hines L, Foley J, Ramezani A . Depression, cognition, and self-appraisal of functional abilities in HIV: an examination of subjective appraisal versus objective performance. Clin Neuropsychol. 2011; 25(2):224-43. PMC: 3616492. DOI: 10.1080/13854046.2010.539577. View

15.

Woods S, Rippeth J, Frol A, Levy J, Ryan E, Soukup V . Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol. 2004; 26(6):759-78. DOI: 10.1080/13803390490509565. View

16.

Chiao S, Rosen H, Nicolas K, Wendelken L, Alcantar O, Rankin K . Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV. AIDS Res Hum Retroviruses. 2013; 29(6):949-56. PMC: 3653396. DOI: 10.1089/AID.2012.0229. View

17.

Schifitto G, Kieburtz K, McDermott M, McArthur J, Marder K, Sacktor N . Clinical trials in HIV-associated cognitive impairment: cognitive and functional outcomes. Neurology. 2001; 56(3):415-8. DOI: 10.1212/wnl.56.3.415. View

18.

Sacktor N, Skolasky R, Seaberg E, Munro C, Becker J, Martin E . Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology. 2016; 86(4):334-40. PMC: 4776086. DOI: 10.1212/WNL.0000000000002277. View

19.

Sacktor N, Lyles R, Skolasky R, Kleeberger C, Selnes O, Miller E . HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998. Neurology. 2001; 56(2):257-60. DOI: 10.1212/wnl.56.2.257. View

20.

Heaton R, Marcotte T, Rivera Mindt M, Sadek J, Moore D, Bentley H . The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004; 10(3):317-31. DOI: 10.1017/S1355617704102130. View